SCHEMBL4843860

SCHEMBL4843860

COC(=O)CCCCOc1ccc(CN)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.52
KEAP1 Q14145 1/20 0.49
NFE2L2 Q16236 1/20 0.49
LOXL2 Q9Y4K0 1/20 0.47
PDE3B Q13370 3/20 0.46
PDE3A Q14432 3/20 0.46
P2RY12 Q9H244 3/20 0.46
HDAC8 Q9BY41 4/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HDAC3 O15379 3/20 0.46
HDAC4 P56524 3/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC7 Q8WUI4 3/20 0.46
HDAC2 Q92769 3/20 0.46
HDAC10 Q969S8 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838190 0.95 LTA4H (0.53) LTA4HKEAP1NFE2L2LOXL2PDE3B
Hydrochloric Acid SCHEMBL25376075 0.94 LTA4H (0.52) LTA4HKEAP1NFE2L2LOXL2PDE3B
SCHEMBL24675523 0.93 LTA4H (0.47) LTA4HKEAP1NFE2L2PDE3BPDE3A
Hydrochloric Acid SCHEMBL25250800 0.92 LTA4H (0.46) LTA4HKEAP1NFE2L2PDE3BPDE3A
SCHEMBL1668551 0.90 LTA4H (0.52) LTA4HKEAP1NFE2L2LOXL2ALDH1A1
SCHEMBL4275826 0.87 HDAC1 (0.56) LTA4HPDE3BPDE3AP2RY12HDAC8
SCHEMBL765954 0.86 LMNA (0.55) LTA4HALDH1A1LMNAMAPTHTT
SCHEMBL4832834 0.85 LOXL2 (0.49) LTA4HLOXL2PDE3BPDE3AP2RY12
SCHEMBL4275916 0.84 LTA4H (0.52) LTA4HPDE3BPDE3AP2RY12HDAC8
SCHEMBL13104320 0.84 LMNA (0.53) LTA4HPDE3BPDE3AP2RY12HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102746214-A Novel indoline compounds FOURNIER LAB SA 2012-10-24 CN disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
EP-0712405-A1 DERIVATIVES OF MONIC ACIDS A AND C HAVING ANTIBACTERIAL, ANTIMYCOPLASMATICAL, ANTIFUNGAL AND HERBICIDAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1996-05-22 EP disclosed
WO-1995005384-A1 DERIVATIVES OF MONIC ACIDS A AND C HAVING ANTIBACTERIAL, ANTIMYCOPLASMATICAL, ANTIFUNGAL AND HERBICIDAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1995-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 LTA4H 1742/4885KEAP1 236/4885NFE2L2 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.